Business

Gilead Sciences, a biopharmaceutical company, recently announced groundbreaking results from a late-stage trial of its experimental twice-yearly HIV prevention medicine, lenacapavir. The trial showcased a remarkable 100% effectiveness in preventing HIV transmission among approximately 2,000 women who received the injectable shot. This development has the potential to revolutionize HIV prevention strategies and expand Gilead’s presence
The recent Chapter 11 bankruptcy filing by Fisker, a once-promising all-electric vehicle startup, adds to a growing list of failed companies in the electric vehicle (EV) industry. Lackluster consumer demand, significant cash burn, operational challenges, and product issues have plagued Fisker, leading to its downfall. The collapse of Fisker follows other SPAC-backed companies such as
Senator Elizabeth Warren has recently accused Federal Reserve Chair Jerome Powell of bowing to pressure from the financial industry. She claims that Powell is advocating for changes to regulations that would decrease the capital large banks are required to hold. Warren’s concern is rooted in the fact that these regulations, known as Basel III, were
Eli Lilly has seen a surge in demand for its weight loss and diabetes treatments in recent times, which has led to a significant increase in its revenue. The outgoing Chief Financial Officer, Anat Ashkenazi, highlighted the company’s success in managing the windfall from its diabetes injection Mounjaro and obesity drug Zepbound. This success has
The much-anticipated merger between Paramount Global and Skydance has come to a screeching halt as National Amusements, owned by Shari Redstone, has decided to stop talks with Skydance regarding the proposed deal. The news, reported by CNBC’s David Faber, sent shockwaves through the industry as stakeholders awaited the outcome. The merger, which was on the